In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools

Vox Sanguinis

Volumn 88, Issue 3, 2005, Pages 164-171

  Turner, C P ^a,c   Sutherland, J ^a   Wadhwa, M ^b   Dilger, P ^b   Cardigan, R ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c NBS Brentwood ^*  (United Kingdom)

Author keywords

Complement activation; Metabolism; Platelet activation; Platelet concentrate; Platelet storage; Storage lesion

Indexed keywords

BLOOD CLOTTING FACTOR 12; CD61 ANTIGEN; GLYCOPROTEIN IB ALPHA; LIPOCORTIN 5; RANTES; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD FILTRATION; COMPLEMENT ACTIVATION; DEVICE; HUMAN; HUMAN CELL; LEUKOPENIA; MUSCLE HYPOTONIA; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

ANALYSIS OF VARIANCE; ANNEXIN A5; ANTIGENS, CD; BLOOD PLATELETS; BLOOD PRESERVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FILTRATION; HUMANS; HYDROGEN-ION CONCENTRATION; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET MEMBRANE GLYCOPROTEINS; PLATELET TRANSFUSION; PROTEIN BINDING; SPECIMEN HANDLING; TIME FACTORS;

EID: 17144424644     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00609.x     Document Type: Article

References (42)

1. Chiu EK, Yuen KY, Lie AK, Liang R, Lau YL, Lee AC, Kwong YL, Wong S, Ng MH, Chan TK: A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion 1994; 34:950-954
2. Blajchman MA: Transfusion-associated bacterial sepsis: the phoenix rises yet again. Transfusion 1994; 34:940-942
3. van der Meer PF, Pietersz R, Reesink H: Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers. Vox Sang 2001; 81:102-107
4. de Wildt-Eggen J, Schrijver JG, Bins M: WBC content of platelet concentrates prepared by the buffy coat method using different processing procedures and storage solutions. Transfusion 2001; 41:1378-1383
5. Klinger MH, Josch M, Kluter H: Platelets stored in a glucose-free additive solution or in autologous plasma - an ultrastructural and morphometric evaluation. Vox Sang 1996; 71:13-20
6. Pietersz RN, van der Meer PF, Steneker I, Hinloopen B, Dekker WJ, van Zanten AP, Reesink HW: Preparation of leukodepleted platelet concentrates from pooled buffy coats: prestorage filtration with Autostop BC. Vox Sang 1999; 76:231-236
7. Larsson S, Gulliksson H, Paunovic D: Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies. Transfusion 2001; 41:534-539
8. Lozano ML, Perez-Ceballos E, Rivera J, Paunovic D, Candela MJ, Vicente V: Evaluation of a new whole-blood filter that allows preparation of platelet concentrates by platelet-rich plasma methods. Transfusion 2003; 43:1723-1728
9. Ashwood ER, Kost, G, Kenny, M: Temperature correction of blood-gas and pH measurements. Clin Chem 1983; 29:1877-1885
10. Bertolini F, Murphy S: A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion 1996; 36:128-132
11. Holme S, Moroff G, Murphy S: A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38:31-40
12. Cardigan R, Sutherland J, Wadhwa M, Dilger P, Thorpe R: The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage. Vox Sang 2003; 84:28-35
13. Kilkson H, Holme S, Murphy S: Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984; 64:406-414
14. Holme S, Heaton WA, Courtright M: Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang 1987; 53:214-220
15. Holme S: Storage and quality assessment of platelets. Vox Sang 1998; 74:207-216
16. Murphy S: Platelet storage for transfusion. Semin Hematol 1985; 22:165-177
17. Murphy S, Gardner FH: Platelet storage at 22 degrees C: role of gas transport across plastic containers in maintenance of viability. Blood 1975; 46:209-218
18. Murphy S, Kahn RA, Holme S, Phillips GL, Sherwood W, Davisson W, Buchholz DH: Improved storage of platelets for transfusion in a new container. Blood 1982; 60:194-200
19. Solberg C, Holme S, Little C: Morphological changes associated with pH changes during storage of platelet concentrates in first-generation 3-day container. Vox Sang 1986; 50:71-77
20. Dumont LJ, VandenBroeke T: Seven-day storage of apheresis platelets: report of an in vitro study. Transfusion 2003; 43:143-150
21. Metcalfe P, Williamson LM, Reutelingsperger CP, Swann I, Ouwehand WH, Goodall AH: Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 1997; 98:86-95
22. Krailadsiri P, Seghatchian J, Williamson LM: Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations. Transfusion 2001; 41:243-250
23. Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR: Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion 1993; 33:25-29
24. George JN, Pickett EB, Heinz R: Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 1988; 28:123-126
25. Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK: The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86:178-188
26. Michelson AD, Adelman B, Barnard MR, Carroll E, Handin RI: Platelet storage results in a redistribution of glycoprotein Ib molecules. Evidence for a large intraplatelet pool of glycoprotein Ib. J Clin Invest 1988; 81:1734-1740
27. Holme S, Bode A, Heaton WA, Sawyer S: Improved maintenance of platelet in vivo viability during storage when using a synthetic medium with inhibitors. J Laboratory Clin Med 1992; 119:144-150
28. van Zanten GH, Heijnen HF, Wu Y, Schut-Hese KM, Slootweg PJ, de Groot PG, Sixma JJ, Nieuwland R: A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions. Blood 1998; 91:2353-2359
29. George JN, Reimann TA, Moake JL, Morgan RK, Cimo PL, Sears DA: Bernard-Soulier disease: a study of four patients and their parents. Br J Haematol 1981; 48:459-467
30. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ: The mechanism of apoptosis in human platelets during storage. Transfusion 2000; 40:1320-1329
31. Pereira J, Soto M, Palomo I, Ocqueteau M, Coetzee LM, Astudillo S, Aranda E, Mezzano D: Platelet aging in vivo is associated with activation of apoptotic pathways: studies in a model of suppressed thrombopoiesis in dogs. Thromb Haemost 2002; 87:905-909
32. Wolf BB, Goldstein JC, Stennicke HR, Beere H, Amarante-Mendes GP, Salvesen GS, Green DR: Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999; 94:1683-1692
33. Fox JE: Cytoskeletal proteins and platelet signaling. Thromb Haemost 2001; 86:198-213
34. Boehlen F, Clemetson KJ: Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 2001; 11:403-417
35. Wakamoto S, Fujihara M, Kuzuma K, Sato S, Kato T, Naohara T, Kasai M, Sawada K, Kobayashi R, Kudoh T, Ikebuchi K, Azuma H, Ikeda H: Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003; 43:1038-1046
36. Kluter H, Bubel S, Kirchner H, Wilhelm D: Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39:1179-1184
37. Kunz D, Luley C, Heim MU, Bock M: Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion 1998; 38:156-159
38. Polley MJ, Nachman RL: Human platelet activation by C3a and C3a des-arg. J Exp Med 1983; 158:603-615
39. Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D: Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion. Inflammation 1981; 5:263-273
40. Yancey KB, Lawley TJ, Dersookian M, Harvath L: Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies. J Invest Dermatol 1989; 92:184-189
41. Holme S, Snyder E, Heaton A, Keegan T, Napychank P: In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis. Transfusion 1992; 32:328-333
42. Scott CF, Brandwein H, Whitbread J, Colman RW: Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters. Blood 1998; 92:616-622